Esperion Therapeutics SG&A Expense (Semi Annual) Insights

Esperion Therapeutics, Inc. (ESPR)

2.55 -0.06 (-2.30%) USD | NASDAQ | Apr 06, 16:00

2.56 +0.01 (+0.39%) After-Hours: 20:00

View SG&A Expense (Semi Annual) for ESPR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Nektar Therapeutics	--
Harrow, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Rigel Pharmaceuticals, Inc.	--